200 related articles for article (PubMed ID: 25540903)
1. Cationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responses.
Zeng Q; Jiang H; Wang T; Zhang Z; Gong T; Sun X
J Control Release; 2015 Feb; 200():1-12. PubMed ID: 25540903
[TBL] [Abstract][Full Text] [Related]
2. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
[TBL] [Abstract][Full Text] [Related]
3. Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis.
Xu Z; Ramishetti S; Tseng YC; Guo S; Wang Y; Huang L
J Control Release; 2013 Nov; 172(1):259-265. PubMed ID: 24004885
[TBL] [Abstract][Full Text] [Related]
4. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocytes responding to low dose TRP2 antigen are induced against B16 melanoma by liposome-encapsulated TRP2 peptide and CpG DNA adjuvant.
Jérôme V; Graser A; Müller R; Kontermann RE; Konur A
J Immunother; 2006; 29(3):294-305. PubMed ID: 16699372
[TBL] [Abstract][Full Text] [Related]
6. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
7. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of dendritic cells loaded with a fusion mRNA encoding tyrosinase-related protein 2 and enhanced green fluorescence protein on B16 melanoma.
Fukui M; Nakano-Hashimoto T; Okano K; Maruta Y; Suehiro Y; Hamanaka Y; Yamashita H; Imai K; Kawano MM; Hinoda Y
Tumour Biol; 2004; 25(5-6):252-7. PubMed ID: 15627888
[TBL] [Abstract][Full Text] [Related]
9. Efficient Delivery of Tyrosinase Related Protein-2 (TRP2) Peptides to Lymph Nodes using Serum-Derived Exosomes.
Park O; Choi ES; Yu G; Kim JY; Kang YY; Jung H; Mok H
Macromol Biosci; 2018 Dec; 18(12):e1800301. PubMed ID: 30407735
[TBL] [Abstract][Full Text] [Related]
10. Trp2 peptide vaccine adjuvanted with (R)-DOTAP inhibits tumor growth in an advanced melanoma model.
Vasievich EA; Ramishetti S; Zhang Y; Huang L
Mol Pharm; 2012 Feb; 9(2):261-8. PubMed ID: 22142394
[TBL] [Abstract][Full Text] [Related]
11. Neutral polymer micelle carriers with pH-responsive, endosome-releasing activity modulate antigen trafficking to enhance CD8(+) T cell responses.
Keller S; Wilson JT; Patilea GI; Kern HB; Convertine AJ; Stayton PS
J Control Release; 2014 Oct; 191():24-33. PubMed ID: 24698946
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment.
Huo M; Zhao Y; Satterlee AB; Wang Y; Xu Y; Huang L
J Control Release; 2017 Jan; 245():81-94. PubMed ID: 27863995
[TBL] [Abstract][Full Text] [Related]
13. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.
Thomas SN; Vokali E; Lund AW; Hubbell JA; Swartz MA
Biomaterials; 2014 Jan; 35(2):814-24. PubMed ID: 24144906
[TBL] [Abstract][Full Text] [Related]
14. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
[TBL] [Abstract][Full Text] [Related]
15. Trp2 Peptide-Assembled Nanoparticles with Intrinsically Self-Chelating
He Z; Jia H; Zheng M; Wang H; Yang W; Gao L; Zhang Z; Xue J; Xu B; Yang W; Xing G; Gao X; Gao F
ACS Appl Bio Mater; 2021 Jul; 4(7):5707-5716. PubMed ID: 35006752
[TBL] [Abstract][Full Text] [Related]
16. Tailoring polymeric hybrid micelles with lymph node targeting ability to improve the potency of cancer vaccines.
Zeng Q; Li H; Jiang H; Yu J; Wang Y; Ke H; Gong T; Zhang Z; Sun X
Biomaterials; 2017 Apr; 122():105-113. PubMed ID: 28110170
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration.
Eggert AA; Schreurs MW; Boerman OC; Oyen WJ; de Boer AJ; Punt CJ; Figdor CG; Adema GJ
Cancer Res; 1999 Jul; 59(14):3340-5. PubMed ID: 10416590
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells break tolerance and induce protective immunity against a melanocyte differentiation antigen in an autologous melanoma model.
Schreurs MW; Eggert AA; de Boer AJ; Vissers JL; van Hall T; Offringa R; Figdor CG; Adema GJ
Cancer Res; 2000 Dec; 60(24):6995-7001. PubMed ID: 11156402
[TBL] [Abstract][Full Text] [Related]
19. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy.
Yang X; Yu T; Zeng Y; Lian K; Zhou X; Li S; Qiu G; Jin X; Yuan H; Hu F
Carbohydr Polym; 2020 Jul; 240():116270. PubMed ID: 32475559
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
